SKP2 triggers K63-linked ubiquitination of Bcr-Abl, regulating downstream signaling, and is vital for chronic myeloid leukemia development and progression (Liao et al., 2019). Here, SKP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.